Background & Objective: In this study the effects of this method on neonatal and the complaints and complications of mothers after Cesarean section by using pharmaceutical composition with opioids in intravenous analgesia pump are examined.

Materials & Methods: This study is an unidirectional clinical trial with a purposive sampling method on100 patients undergoing elective cesarean section in 2014 were admitted to the Sadjad hospital in Kermanshah. The patients were divided into two groups of 50 people, namely, pain control by using intravenous injection pump (intervention group) and pain control by using non-steroidal anti-inflammatory drugs (control group). Data collection tools, including check list of demographic, maternal and neonatal reflexes of discharge and a week after Cesarean. T-student test was used to compare quantitative variables and ratio test was used to compare qualitative variables. P values ​​less than 0.05 were considered significant.

Results: Test results showed statistically significant differences in maternal complications between the intervention and control group at discharge (p<0/001). However, no significant difference in overall complications for the mothers between the intervention and control group during the first week after cesarean were showed. Also, in the case of neonatal reflexes  no significant differences between the two groups were observed.

Conclusion: By adding pharmaceutical compounds to the intravenous pumps, it is possible to provide further use of this method of analgesia in women who have undergone Cesarean.